Rhythm Pharmaceuticals
(NASDAQ:RYTM)
$42.99
1.20[2.87%]
Last update: 9:25AM Get Real Time Here
Consensus Rating1
Buy
Highest Price Target1
$56.00
Lowest Price Target1
$25.00
Consensus Price Target1
$43.45

Rhythm Pharmaceuticals Stock (NASDAQ:RYTM), Analyst Ratings, Price Targets, Predictions

Rhythm Pharmaceuticals Inc has a consensus price target of $43.45, established from looking at the 45 latest analyst ratings. The last 3 analyst ratings were released from Needham, Goldman Sachs, and Needham on February 22, 2024, January 26, 2024, and January 26, 2024. With an average price target of $50.67 between Needham, Goldman Sachs, and Needham, there's an implied 17.86% upside for Rhythm Pharmaceuticals Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Oct 23
1
Nov 23
1
Dec 23
4
Jan
4
Feb
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Needham
Goldman Sachs
Morgan Stanley
Wells Fargo
B of A Securities

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Rhythm Pharmaceuticals

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
02/22/2024RYTMBuy Now
Rhythm Pharmaceuticals
$42.9916.31%Needham
Joseph Stringer
→ $50ReiteratesBuy → BuyGet Alert
01/26/2024RYTMBuy Now
Rhythm Pharmaceuticals
$42.9920.96%Goldman Sachs
Corinne Jenkins
$42 → $52MaintainsBuyGet Alert
01/26/2024RYTMBuy Now
Rhythm Pharmaceuticals
$42.9916.31%Needham
Joseph Stringer
→ $50ReiteratesBuy → BuyGet Alert
01/25/2024RYTMBuy Now
Rhythm Pharmaceuticals
$42.9920.96%Goldman Sachs
Corinne Jenkins
$42 → $52MaintainsBuyGet Alert
01/04/2024RYTMBuy Now
Rhythm Pharmaceuticals
$42.9916.31%Needham
Joseph Stringer
$45 → $50MaintainsBuyGet Alert
12/19/2023RYTMBuy Now
Rhythm Pharmaceuticals
$42.9927.94%Morgan Stanley
Jeffrey Hung
$29 → $55UpgradeEqual-Weight → OverweightGet Alert
12/19/2023RYTMBuy Now
Rhythm Pharmaceuticals
$42.9923.28%Wells Fargo
Derek Archila
$48 → $53MaintainsOverweightGet Alert
12/07/2023RYTMBuy Now
Rhythm Pharmaceuticals
$42.99-2.3%Goldman Sachs
Corinne Jenkins
$38 → $42MaintainsBuyGet Alert
12/07/2023RYTMBuy Now
Rhythm Pharmaceuticals
$42.994.68%Needham
Joseph Stringer
$32 → $45MaintainsBuyGet Alert
11/08/2023RYTMBuy Now
Rhythm Pharmaceuticals
$42.99-6.96%Wells Fargo
Derek Archila
$38 → $40MaintainsOverweightGet Alert
10/10/2023RYTMBuy Now
Rhythm Pharmaceuticals
$42.99-32.54%Morgan Stanley
Jeffrey Hung
$28 → $29MaintainsEqual-WeightGet Alert
08/02/2023RYTMBuy Now
Rhythm Pharmaceuticals
$42.99-34.87%Morgan Stanley
Jeffrey Hung
$28 → $28ReiteratesEqual-Weight → Equal-WeightGet Alert
08/02/2023RYTMBuy Now
Rhythm Pharmaceuticals
$42.99-37.19%B of A Securities
Tazeen Ahmad
$22 → $27UpgradeNeutral → BuyGet Alert
08/02/2023RYTMBuy Now
Rhythm Pharmaceuticals
$42.99-25.56%Needham
Joseph Stringer
→ $32ReiteratesBuy → BuyGet Alert
06/20/2023RYTMBuy Now
Rhythm Pharmaceuticals
$42.99-25.56%Needham
Joseph Stringer
→ $32ReiteratesBuy → BuyGet Alert
04/18/2023RYTMBuy Now
Rhythm Pharmaceuticals
$42.99-25.56%Needham
Joseph Stringer
→ $32Reiterates → BuyGet Alert
03/02/2023RYTMBuy Now
Rhythm Pharmaceuticals
$42.99-34.87%Morgan Stanley
Jeffrey Hung
$26 → $28MaintainsEqual-WeightGet Alert
03/02/2023RYTMBuy Now
Rhythm Pharmaceuticals
$42.9930.26%Canaccord Genuity
Whitney Ijem
$52 → $56MaintainsBuyGet Alert
03/02/2023RYTMBuy Now
Rhythm Pharmaceuticals
$42.994.68%Goldman Sachs
Corinne Jenkins
$40 → $45MaintainsBuyGet Alert

FAQ

Q

What is the target price for Rhythm Pharmaceuticals (RYTM)?

A

The latest price target for Rhythm Pharmaceuticals (NASDAQ: RYTM) was reported by Needham on February 22, 2024. The analyst firm set a price target for $50.00 expecting RYTM to rise to within 12 months (a possible 16.31% upside). 16 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Rhythm Pharmaceuticals (RYTM)?

A

The latest analyst rating for Rhythm Pharmaceuticals (NASDAQ: RYTM) was provided by Needham, and Rhythm Pharmaceuticals reiterated their buy rating.

Q

When was the last upgrade for Rhythm Pharmaceuticals (RYTM)?

A

The last upgrade for Rhythm Pharmaceuticals Inc happened on December 19, 2023 when Morgan Stanley raised their price target to $55. Morgan Stanley previously had an equal-weight for Rhythm Pharmaceuticals Inc.

Q

When was the last downgrade for Rhythm Pharmaceuticals (RYTM)?

A

The last downgrade for Rhythm Pharmaceuticals Inc happened on November 19, 2021 when Morgan Stanley changed their price target from $50 to $15 for Rhythm Pharmaceuticals Inc.

Q

When is the next analyst rating going to be posted or updated for Rhythm Pharmaceuticals (RYTM)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Rhythm Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Rhythm Pharmaceuticals was filed on February 22, 2024 so you should expect the next rating to be made available sometime around February 22, 2025.

Q

Is the Analyst Rating Rhythm Pharmaceuticals (RYTM) correct?

A

While ratings are subjective and will change, the latest Rhythm Pharmaceuticals (RYTM) rating was a reiterated with a price target of $0.00 to $50.00. The current price Rhythm Pharmaceuticals (RYTM) is trading at is $42.99, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch